Concepts (70)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pregnancy Complications, Infectious | 5 | 2022 | 44 | 2.130 |
Why?
|
| Streptococcus agalactiae | 2 | 2022 | 11 | 1.470 |
Why?
|
| Streptococcal Infections | 2 | 2022 | 34 | 1.440 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2022 | 13 | 0.790 |
Why?
|
| Specimen Handling | 1 | 2022 | 30 | 0.790 |
Why?
|
| Mass Screening | 1 | 2022 | 141 | 0.730 |
Why?
|
| Infectious Disease Transmission, Vertical | 2 | 2019 | 13 | 0.720 |
Why?
|
| Pregnancy Outcome | 1 | 2020 | 128 | 0.670 |
Why?
|
| Pregnancy Complications | 1 | 2020 | 105 | 0.650 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2019 | 37 | 0.650 |
Why?
|
| Pregnancy | 7 | 2022 | 1131 | 0.600 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2020 | 322 | 0.550 |
Why?
|
| Premature Birth | 1 | 2016 | 48 | 0.500 |
Why?
|
| Anti-Bacterial Agents | 1 | 2019 | 496 | 0.490 |
Why?
|
| Zika Virus | 3 | 2020 | 28 | 0.470 |
Why?
|
| Zika Virus Infection | 3 | 2020 | 28 | 0.470 |
Why?
|
| Vagina | 2 | 2022 | 42 | 0.370 |
Why?
|
| Infant, Newborn | 3 | 2020 | 843 | 0.310 |
Why?
|
| Female | 8 | 2022 | 14463 | 0.270 |
Why?
|
| Perineum | 1 | 2022 | 14 | 0.200 |
Why?
|
| Rectum | 1 | 2022 | 50 | 0.200 |
Why?
|
| Viremia | 2 | 2019 | 16 | 0.190 |
Why?
|
| Blood Glucose Self-Monitoring | 1 | 2020 | 16 | 0.180 |
Why?
|
| Monkey Diseases | 1 | 2020 | 16 | 0.170 |
Why?
|
| Humans | 6 | 2022 | 26828 | 0.170 |
Why?
|
| Cesarean Section | 1 | 2020 | 55 | 0.170 |
Why?
|
| Semen | 1 | 2020 | 27 | 0.170 |
Why?
|
| Penicillins | 1 | 2019 | 10 | 0.170 |
Why?
|
| Drug Hypersensitivity | 1 | 2019 | 22 | 0.170 |
Why?
|
| Diabetes, Gestational | 1 | 2019 | 63 | 0.160 |
Why?
|
| Cohort Studies | 1 | 2020 | 858 | 0.150 |
Why?
|
| Adult | 2 | 2020 | 7383 | 0.150 |
Why?
|
| Antibodies, Viral | 1 | 2018 | 74 | 0.150 |
Why?
|
| Cerebral Cortex | 1 | 2019 | 133 | 0.150 |
Why?
|
| Disease Models, Animal | 2 | 2019 | 1393 | 0.130 |
Why?
|
| Amino Acids, Aromatic | 1 | 2014 | 2 | 0.120 |
Why?
|
| Phenylalanine | 1 | 2014 | 23 | 0.120 |
Why?
|
| Tryptophan | 1 | 2014 | 39 | 0.120 |
Why?
|
| Osteoclasts | 1 | 2014 | 28 | 0.120 |
Why?
|
| Tyrosine | 1 | 2014 | 90 | 0.110 |
Why?
|
| Retrospective Studies | 1 | 2020 | 2433 | 0.110 |
Why?
|
| Young Adult | 1 | 2019 | 2581 | 0.100 |
Why?
|
| Risk Factors | 1 | 2016 | 2011 | 0.090 |
Why?
|
| Papio anubis | 2 | 2020 | 40 | 0.080 |
Why?
|
| Animals | 4 | 2020 | 9961 | 0.060 |
Why?
|
| RNA, Viral | 1 | 2020 | 67 | 0.040 |
Why?
|
| Postprandial Period | 1 | 2019 | 41 | 0.040 |
Why?
|
| Microcephaly | 1 | 2019 | 8 | 0.040 |
Why?
|
| Fetal Death | 1 | 2019 | 21 | 0.040 |
Why?
|
| Fetal Diseases | 1 | 2019 | 18 | 0.040 |
Why?
|
| Feasibility Studies | 1 | 2019 | 187 | 0.040 |
Why?
|
| Immunoglobulin M | 1 | 2018 | 28 | 0.040 |
Why?
|
| Brazil | 1 | 2018 | 21 | 0.040 |
Why?
|
| Mucous Membrane | 1 | 2018 | 26 | 0.040 |
Why?
|
| Fetus | 1 | 2019 | 77 | 0.040 |
Why?
|
| Placenta | 1 | 2019 | 74 | 0.040 |
Why?
|
| Papio | 1 | 2018 | 78 | 0.040 |
Why?
|
| Male | 3 | 2020 | 12870 | 0.040 |
Why?
|
| Blood Glucose | 1 | 2019 | 300 | 0.040 |
Why?
|
| Immunoglobulin G | 1 | 2018 | 266 | 0.030 |
Why?
|
| Bone Resorption | 1 | 2014 | 23 | 0.030 |
Why?
|
| In Vitro Techniques | 1 | 2014 | 238 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2014 | 129 | 0.030 |
Why?
|
| Brain | 1 | 2019 | 699 | 0.030 |
Why?
|
| Diet | 1 | 2014 | 223 | 0.030 |
Why?
|
| Dietary Supplements | 1 | 2014 | 213 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2014 | 395 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2014 | 970 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2014 | 1476 | 0.020 |
Why?
|
| Mice | 1 | 2014 | 4407 | 0.020 |
Why?
|